People who stop taking anti-obesity drugs will within two years return to their original weight and forfeit benefits to the heart, cholesterol levels and blood pressure, according to projections based on a wide-ranging research review.
The findings add to evidence of difficulties in sustaining the significant weight loss and associated health advantages many people achieve while they use drugs such as Ozempic, Wegovy and Mounjaro.
Experts warn that health authorities need plans to deal with millions of users who will come off the popular medicines during the coming years.
您已阅读15%（576字），剩余85%（3314字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。